|
|
|
Biological Activity:
Selective protein kinase C beta (PKCβ) inhibitor; Enzastaurin inhibits PKCβ, PKCα, PKCγ and PKCε with IC50's of 6, 39, 83 and 110 nM, respectively.
References:
JR Graff et al. The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts. Cancer Res. 2005, 65, 7462-7469. [online]
MA Rizvi et al. Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Mol. Cancer Ther. 2006, 5, 1783-1789. [online]
Chemical Name: 3-(1-Methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione
|
| Enzastaurin - LY 317615 | PKCβ Inhibitor | Axon Medchem | Axon 1682 | LY317615 |
|
Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.
axonmedchem.com © 2011 |
![]() |
Axon Ligands In The Field:
AEB 071 | PKC inhibitor
LY 317615 | PKCβ inhibitor
LY 333531 | PKCβ inhibitor
CID 755673 | PKD inhibitor
Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection |